Patents by Inventor Leah R. Bresin Hanson

Leah R. Bresin Hanson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating patients with impaired awareness of hypoglycemia
    Patent number: 11013873
    Abstract: The present system is directed in one embodiment to a method of administration of a therapeutic composition for treatment, prevention and/or mitigation of the frequency and/or severity of impaired awareness of hypoglycemia (IAH). The method includes administering one or more therapeutic agent(s) or composition(s) comprising insulin to the upper third of a patient's nasal cavity, thereby delivering the therapeutic composition directly to the patient's central nervous system for treatment, prevention and/or mitigation of the frequency and/or severity of IAH. In still another embodiment, the therapeutic composition comprises a non-zinc containing form of insulin.
    Type: Grant
    Filed: January 4, 2018
    Date of Patent: May 25, 2021
    Assignee: HealthPartners Institite
    Inventors: William H. Frey, II, Richard M. Bergenstal, Leah R. Bresin Hanson, Anders L. Carlson
  • METHODS OF TREATING EPILEPSY, SEIZURE DISORDERS AND SUDDEN UNEXPECTED DEATH IN EPILEPSY
    Publication number: 20190060414
    Abstract: The present system is directed in several embodiments to a method of administration of a therapeutic composition for treatment of seizures resulting from epilepsy and other seizure disorders. The method includes administering one or more therapeutic compositions comprising an effective amount of insulin directly to the subject patient's CNS, with no to minimal systemic exposure. Preferably, this method comprises administration of an effective amount of insulin to the upper third of a patient's nasal cavity, thereby bypassing the patient's blood-brain barrier and delivering the therapeutic composition directly to the patient's central nervous system.
    Type: Application
    Filed: August 24, 2018
    Publication date: February 28, 2019
    Inventors: William H. Frey, II, Leah R. Bresin Hanson
  • METHODS FOR PREVENTING AND TREATING PATIENTS WITH IMPAIRED AWARENESS OF HYPOGLYCEMIA
    Publication number: 20180193576
    Abstract: The present system is directed in one embodiment to a method of administration of a therapeutic composition for treatment, prevention and/or mitigation of the frequency and/or severity of impaired awareness of hypoglycemia (IAH). The method includes administering one or more therapeutic agent(s) or composition(s) comprising insulin to the upper third of a patient's nasal cavity, thereby delivering the therapeutic composition directly to the patient's central nervous system for treatment, prevention and/or mitigation of the frequency and/or severity of IAH. In still another embodiment, the therapeutic composition comprises a non-zinc containing form of insulin.
    Type: Application
    Filed: January 4, 2018
    Publication date: July 12, 2018
    Inventors: William H. Frey, II, Richard M. Bergenstal, Leah R. Bresin Hanson, Anders L. Carlson